文献速递胸部肿瘤放疗放疗物理与技术

靶向DNA依赖蛋白激酶联合碳离子照射克服非小细胞肺癌缺氧诱导的放疗抵抗

Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation.
PubMed 文献 · Radiat Oncol · 2017-12-29

该研究在A549和H1437非小细胞肺癌细胞模型中,比较常氧(21% O2)与缺氧(1% O2)条件下光子及碳离子照射联合DNA-PK抑制剂M3814或ATM抑制剂的放射敏感性。结果显示碳离子照射未见显著氧效应,DNA-PK抑制剂在缺氧条件下放射增敏作用更强,碳离子联合DNA损伤修复抑制为最有效方案。

要点

  • 碳离子照射在缺氧条件下未见显著氧效应,可有效杀灭缺氧肿瘤细胞。
  • DNA-PK抑制剂M3814在缺氧条件下对放射的增敏作用强于常氧条件。
  • 碳离子照射联合DNA损伤修复抑制为最有效的治疗组合。

核心结论

  • 碳离子可有效清除缺氧肿瘤细胞,DNA-PK抑制剂优先增敏缺氧细胞对放疗的反应,碳离子联合DNA损伤修复抑制为最有效方案。

研究设计与样本

  • 研究使用人非小细胞肺癌模型A549和H1437,在缺氧(1% O2)与常氧(21% O2)条件下接受系列剂量光子或碳离子照射。
  • 照射后采用克隆存活实验评估放疗与DNA-PK抑制剂M3814及ATM抑制剂双联合的效果。

主要发现

  • A549细胞光子照射30%存活水平的OER为1.4,8 Gy光子照射时以存活比表示的最大氧效应为2.34。
  • 碳离子照射后未发现显著氧效应,6 Gy碳离子的相对效应在常氧下为3.8、缺氧下为4.11。
  • 100 nM DNA-PK抑制剂使4 Gy照射的存活比从常氧下1.59增至缺氧下3.3,显示缺氧下强放射增敏作用。
  • 光子照射联合ATM抑制剂在缺氧下该比值仅中度增加,碳离子联合DNA损伤修复抑制为最有效治疗。

临床怎么用

  • 针对缺氧非小细胞肺癌,可考虑碳离子放疗以规避氧效应导致的放射抵抗。
  • DNA-PK抑制剂联合放疗可能优先增敏缺氧肿瘤细胞,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypoxia-induced radioresistance constitutes a major obstacle for a curative treatment of cancer. The aim of this study was to investigate effects of photon and carbon ion irradiation in combination with inhibitors of DNA-Damage Response (DDR) on tumor cell radiosensitivity under hypoxic conditions. METHODS: Human non-small cell lung cancer (NSCLC) models, A549 and H1437, were irradiated with dose series of photon and carbon ions under hypoxia (1% O2) vs. normoxic conditions (21% O2). Clonogenic survival was studied after dual combinations of radiotherapy with inhibitors of DNA-dependent Protein Kinase (DNAPKi, M3814) and ATM serine/threonine kinase (ATMi). RESULTS: The OER at 30% survival for photon irradiation of A549 cells was 1.4. The maximal oxygen effect measured as survival ratio was 2.34 at 8 Gy photon irradiation of A549 cells. In contrast, no significant oxygen effect was found after carbon ion irradiation. Accordingly, the relative effect of 6 Gy carbon ions was determined as 3.8 under normoxia and. 4.11 under hypoxia. ATM and DNA-PK inhibitors dose dependently sensitized tumor cells for both radiation qualities. For 100 nM DNAPKi the survival ratio at 4 Gy more than doubled from 1.59 under normoxia to 3.3 under hypoxia revealing a strong radiosensitizing effect under hypoxic conditions. In contrast, this ratio only moderately increased after photon irradiation and ATMi under hypoxia. The most effective treatment was combined carbon ion irradiation and DNA damage repair inhibition. CONCLUSIONS: Carbon ions efficiently eradicate hypoxic tumor cells. Both, ATMi and DNAPKi elicit radiosensitizing effects. DNAPKi preferentially sensitizes hypoxic cells to radiotherapy.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Klein C, Dokic I, Mairani A, et al. Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation. Radiat Oncol. 2017. PMID: 29287602. doi:10.1186/s13014-017-0939-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。